Characterization of side population cells in human malignant mesothelioma cell lines.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Lung Cancer

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.lungcan.2010.04.020PMID 20493579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of Notch signaling in human cervical cancer: implications for solid tumors

  2008cited by this paper
• Side population cells in human cancers.

  2008cited by this paper
• Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.

  2007cited by this paper
• Most C6 cells are cancer stem cells: evidence from clonal and population analyses.

  2007cited by this paper
• Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

  2007cited by this paper
• The biology of cancer stem cells.

  2007influential reference
• Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells

  2007cited by this paper
• Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

  2007cited by this paper
• Major carcinogenic pathways identified by gene expression analysis of peritoneal mesotheliomas following chemical treatment in F344 rats.

  2006cited by this paper
• Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.

  2006cited by this paper
• From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion.

  2006cited by this paper
• From Adult Stem Cells to Cancer Stem Cells

  2006cited by this paper
• Notch signalling regulates stem cell numbers in vitro and in vivo

  2006cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Opinion: the origin of the cancer stem cell: current controversies and new insights.

  2005cited by this paper
• Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

  2005cited by this paper
• The origin of the cancer stem cell: current controversies and new insights

  2005cited by this paper
• Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.

  2002cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• The pathogenesis of mesothelioma.

  2002cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001influential reference
• An age, period and cohort analysis of pleural cancer mortality in Europe.

  2000cited by this paper
• An age, period and cohort analysis of pleural cancer mortality in Europe.

  2000cited by this paper
• Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

  1996cited by this paper

• SATB2 Induces Malignant Transformation and Cancer Stem Cell Characteristics, and Inhibition of Its Expression Reverses Drug Resistance in Mesothelioma

  2026cites this paper
• SLC13A5 plays an essential role in the energy shift to oxidative phosphorylation in cisplatin‐resistant mesothelioma stem cells

  2025cites this paper
• Combined quetiapine and radiation therapy approach to treat mesothelioma-initiating cells and increase survival in a mouse model of mesothelioma

  2025cites this paper
• An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma

  2025cites this paper
• The application of cancer stem cell model in malignant mesothelioma.

  2022cites this paper
• Partial EMT in Squamous Cell Carcinoma: A Snapshot

  2021cites this paper
• Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms

  2021cites this paper
• Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population

  2021cites this paper
• How Inhaled Asbestos Causes Scarring and Cancer

  2019cites this paper
• Wnt/IL‐1β/IL‐8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5

  2019cites this paper
• Meet Our Editorial Board Member

  2019cites this paper
• Identification of cancer stem cells in malignant pleural mesothelioma

  2019influential citation
• Heterogeneity in Malignant Pleural Mesothelioma

  2018cites this paper
• 2 Stem Cells and Mesothelioma

  2017cites this paper
• A subset of microRNAs defining the side population of a human malignant mesothelioma cell line

  2017cites this paper
• Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway

  2017influential citation
• Circulating tumor cells in lung cancer: cluster circulating tumor cells as hybrid epithelial-mesenchymal transition/mesenchymal-epithelial transition (E/M).

  2017cites this paper
• 22 The Potential Target Therapy of Prostate Cancer Stem Cells

  2017cites this paper
• The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells

  2017cites this paper
• A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential

  2016cites this paper
• Sorting and biological characteristics analysis for side population cells in human primary hepatocellular carcinoma.

  2016cites this paper
• Lung cancer stem cells: The root of resistance.

  2016cites this paper
• Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells

  2016cites this paper
• Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies.

  2016cites this paper
• Biological characteristics of side population cells in a self-established human ovarian cancer cell line

  2016cites this paper
• An Integrated Analysis of the Genome-Wide Profiles of DNA Methylation and mRNA Expression Defining the Side Population of a Human Malignant Mesothelioma Cell Line

  2016cites this paper
• Isolation and characterization of stem cells from human central nervous system malignancies.

  2015cites this paper
• Inhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines

  2015cites this paper
• Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma

  2014cites this paper
• Targeting glioblastoma cancer stem cells: the next great hope?

  2014cites this paper
• Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells.

  2013cites this paper
• Evaluation of a side population of canine lymphoma cells using Hoechst 33342 dye

  2013cites this paper
• Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma

  2012cites this paper
• Stem Cells and Mesothelioma

  2012cites this paper
• The Potential Target Therapy of Prostate Cancer Stem Cells

  2011cites this paper
• Identification and characterization of tumour initiating cells from gynaecological malignancies

  2011cites this paper
• Side population cells in human gallbladder cancer cell line GBC-SD regulated by TGF-β-induced epithelial-mesenchymal transition

  2011cites this paper
• Application of Stem Cell Assays for the Characterization of Cancer Stem Cells

  2011cites this paper
• Pleural mesothelioma side populations have a precursor phenotype.

  2011cites this paper